Created at Source Raw Value Validated value
June 25, 2024, noon usa

* patients with hiv * patients with cancer undergoing chemotherapy * patients receiving immune mediators * patients need hospitalization in the intensive care unit * patients with uncontrolled heart, kidney or liver failure * pregnant or lactating women * intolerance to the drugs used in this study (symptoms such as diarrhea, nausea, vomiting and respiratory problems)

* patients with hiv * patients with cancer undergoing chemotherapy * patients receiving immune mediators * patients need hospitalization in the intensive care unit * patients with uncontrolled heart, kidney or liver failure * pregnant or lactating women * intolerance to the drugs used in this study (symptoms such as diarrhea, nausea, vomiting and respiratory problems)

Oct. 26, 2020, 11:31 p.m. usa

- patients with hiv - patients with cancer undergoing chemotherapy - patients receiving immune mediators - patients need hospitalization in the intensive care unit - patients with uncontrolled heart, kidney or liver failure - pregnant or lactating women - intolerance to the drugs used in this study (symptoms such as diarrhea, nausea, vomiting and respiratory problems)

- patients with hiv - patients with cancer undergoing chemotherapy - patients receiving immune mediators - patients need hospitalization in the intensive care unit - patients with uncontrolled heart, kidney or liver failure - pregnant or lactating women - intolerance to the drugs used in this study (symptoms such as diarrhea, nausea, vomiting and respiratory problems)